Danazol_NN
decreases_VBZ
transcription_NN
of_IN
estrogen_NN
receptor_NN
gene_NN
in_IN
human_JJ
monocytes_NNS
._.

1_LS
._.
Administration_NN
of_IN
danazol_NN
for_IN
over_IN
one_CD
month_NN
reduced_VBD
the_DT
levels_NNS
of_IN
estrogen_NN
receptor_NN
-LRB-_-LRB-
ER_NN
-RRB-_-RRB-
and_CC
its_PRP$
mRNA_NN
to_TO
approximately_RB
50_CD
and_CC
20_CD
%_NN
,_,
respectively_RB
in_IN
monocytes_NNS
._.

2_LS
._.
Danazol_NN
did_VBD
not_RB
alter_VB
the_DT
degradation_NN
rate_NN
of_IN
ER_NN
mRNA_NN
in_IN
monocytes_NNS
._.

3_LS
._.
Danazol_NN
decreased_VBD
the_DT
transcription_NN
rate_NN
of_IN
ER_NN
gene_NN
to_TO
approximately_RB
50_CD
%_NN
in_IN
monocytes_NNS
in_IN
a_DT
run-on_JJ
assay_NN
._.

4_LS
._.
Danazol_NN
may_MD
release_VB
estrogen_NN
predominance_NN
via_IN
the_DT
reduction_NN
of_IN
transcription_NN
for_IN
ER_NN
gene_NN
,_,
which_WDT
leads_VBZ
to_TO
the_DT
reduction_NN
of_IN
ER_NN
mRNA_NN
and_CC
ER_NN
expressions_NNS
in_IN
monocytes_NNS
._.

